Posted inMarket H.C. Wainwright Reaffirms Ionis Stock Rating Following Zanvastro Approval H.C. Wainwright maintains its stock rating for Ionis Pharmaceuticals following the regulatory approval of Zanvastro, highlighting market confidence. Posted by Prasenjit Bhowmik October 3, 2026
